Carfilzomib reverses pulmonary arterial hypertension.

Item

http://www.wikidata.org/entity/Q36812649

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Carfilzomib reverses pulmonary arterial hypertension.

@ast

Carfilzomib reverses pulmonary arterial hypertension.

@en

type

Item

label

Carfilzomib reverses pulmonary arterial hypertension.

@ast

Carfilzomib reverses pulmonary arterial hypertension.

@en

prefLabel

Carfilzomib reverses pulmonary arterial hypertension.

@ast

Carfilzomib reverses pulmonary arterial hypertension.

@en

P1476

Carfilzomib reverses pulmonary arterial hypertension.

@en

P2093

Dividutta Das

http://www.w3.org/2001/XMLSchema#string

Makhosazane Zungu-Edmondson

http://www.w3.org/2001/XMLSchema#string

Nataliia V Shults

http://www.w3.org/2001/XMLSchema#string

Xinhong Wang

http://www.w3.org/2001/XMLSchema#string

Yasmine F Ibrahim

http://www.w3.org/2001/XMLSchema#string

Yuichiro J Suzuki

http://www.w3.org/2001/XMLSchema#string

P2860

TP53INP1, a tumor suppressor, interacts with LC3 and ATG8-family proteins through the LC3-interacting region (LIR) and promotes autophagy-dependent cell death

Mito-tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model

The structure of rat liver vault at 3.5 angstrom resolution

Autophagy in the Pathogenesis of Disease

Regulation of Bcl-xL expression in lung vascular smooth muscle

Velcade: U.S. FDA approval for the treatment of multiple myeloma progressing on prior therapy.

U.s. Food and Drug Administration approval: carfilzomib for the treatment of multiple myeloma.

Analysis of the lung allocation score estimation of risk of death in patients with pulmonary arterial hypertension using data from the REVEAL Registry.

Severe pulmonary arterial hypertension induced by SU5416 and ovalbumin immunization.

Apoptosis meets proteasome, an invaluable therapeutic target of anticancer drugs.

P304

188-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/CVR/CVW047

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

110

http://www.w3.org/2001/XMLSchema#string

P577

2016-03-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26952044

http://www.w3.org/2001/XMLSchema#string

P932

4836627

http://www.w3.org/2001/XMLSchema#string